Hostname: page-component-7dd5485656-kp629 Total loading time: 0 Render date: 2025-10-31T19:36:39.634Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of Neuroleptic Drugs on MAO Activity

Published online by Cambridge University Press:  29 January 2018

Adrianne M. Reveley ,
Michael A. Reveley  and
Robin M. Murray
Adrianne M. Reveley
Affiliation:
Institute of Psychiatry, De Crespigny Park, Denmark Hill
Michael A. Reveley
Affiliation:
Charing Cross Hospital Medical School
Robin M. Murray
Affiliation:
Institute of Psychiatry
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Correspondence
Information
The British Journal of Psychiatry , Volume 139 , Issue 5 , November 1981 , pp. 475 - 476
Copyright
Copyright © Royal College of Psychiatrists, 1981 

References

Hussein, L., Sindarto, E. & Goedde, H. W. (1980) Twin studies- and substrate differences in platelet monoamine oxidase activity. Human Heredity, 30, 65—70.Google Scholar
Koide, Y., Eberhard, G., Säaf, J., Ross, S. B., Wahlund, L-O. & Wetterberg, L. (1981) Kinetic aspects of monoamine oxidase activity in twins with psychosis. Clinical Genetics. CrossRefGoogle Scholar
Nies, A., Robinson, D. S., Lamborn, K. R. & Lampert, R. P. (1973) Genetic control of platelet and plasma monoamine oxidase activity. Archives of General Psychiatry, 28, 834–8.Google Scholar
Owen, F., Bourne, R. C., Crow, T. J., Fadhli, A. A. & Johnstone, E. C. (1981) Platelet monoamine oxidase activity in acute schizophrenia: Relationship to symptomatology and neuroleptic medication. British Journal of Psychiatry, 139, 16—22.Google Scholar
Reveley, M. A., Gurling, H. M. D., Glass, A., Glover, V. & Sandler, M. (1980) Platelet and amirobutyric acid-aminotransferase and monoamine oxidase in schizophrenia. Neuropharmacology, 19, 1249–50.Google Scholar
Spitzer, R., Endicott, J. & Robins, E. (1975) Research Diagnostic Criteria. Instrument No 58. New York: New York State Psychiatric Institute.Google Scholar
Winter, H., Herschel, M., Propping, P., Friedel, W. & Vogel, F. (1978) A twin study in three enzymes. (DBH, COMT, MAO) of catecholamine metabolism: Correlations with MMPI. Psychopharmacology, 57, 63–9.Google Scholar
Wyatt, R. J., Murphy, D. L., Belmaker, R., Cohen, S., Donnelly, C. H. & Pollin, W. (1973) Reduced monoamine oxidase activity in platelets: A possible genetic marker for vulnerability to schizophrenia. Science, 173, 916–18.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.